Edwards Lifesciences (EW) Liabilities from Discontinued Operations (2023 - 2025)

Edwards Lifesciences' Liabilities from Discontinued Operations history runs 3 years deep, the most recent figure standing at 2300000.0 for Q3 2025.

• On a quarterly basis, Liabilities from Discontinued Operations rose 27.78% year-over-year to 2300000.0 in Q3 2025; TTM through Sep 2025 was 2300000.0, a 27.78% increase from a year earlier, with the FY2024 full-year figure at 2000000.0, down 92.03% from the prior year.
• Liabilities from Discontinued Operations steadied at 2300000.0 in Q3 2025 per EW's latest filing, from 2300000.0 in the prior quarter.
• Across five years, Liabilities from Discontinued Operations topped out at 30000000.0 in Q2 2024 and bottomed at 1800000.0 in Q3 2024.
• The 3-year median for Liabilities from Discontinued Operations is 2300000.0 (2025), against an average of 9400000.0.
• Biggest YoY gain for Liabilities from Discontinued Operations was 27.78% in 2025; the steepest drop was 92.33% in 2025.
• Year by year, Liabilities from Discontinued Operations stood at 25100000.0 in 2023, then tumbled by 92.03% to 2000000.0 in 2024, then increased by 15.0% to 2300000.0 in 2025.
• Per Business Quant, the three latest EW Liabilities from Discontinued Operations figures stand at 2300000.0 (Q3 2025), 2300000.0 (Q2 2025), and 2300000.0 (Q1 2025).